Abnormal activation of NFkappaB is also present in >50% of patients and may also revert to normal during IL-2/ IFN alpha -based treatment .
abnormal activation of nfkappab is also present in >50% of patients and may also revert to normal during il-2/ ifn alpha -based treatment .
O O O B-protein_complex O O O O O O B-multi_cell O O O O O O O O B-protein_molecule I-protein_molecule O O O